$JSPR
Jasper Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$16.86
▲After hours+0.00%+$0.000After hours
Jasper Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is JSPR up today? It is at $16.86 (+19.78%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JSPR spikes, and full due diligence on JSPR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JSPR 16 times in the last 30 days. Create a free account to track $JSPR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on JSPR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystJasper Therapeutics Announces 1-for-30 ReverseReported and outstanding share of Common Stock without any change in the par value of $0.0001 per share. No fractional shares will be issued asReported not remain above $1.00 per share; that the reverse stock split may reduce the liquidity of Jasper's common stock; that, becauseReverse split 1-for-30Status pending stockholder approval, from the latest SEC filing. Read it →* Institutional ownership was unavailable, so float is insider-deduped only.
Across every filing on file, supply equal to 23.5% of the tradeable float is in play - 23.5% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $132.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on JSPR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
JSPR last traded at $16.86, up 19.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The JSPR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JSPR 16 times in the last 30 days.
JSPR (Jasper Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $561M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JSPR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JSPR discussion
Sign in to ask a question or join the discussion.